Indian peptide therapeutics market is anticipated to project a CAGR of 7.6%, during the forecast period. India is one of the potential markets for peptide therapeutics particularly due to a high prevalence of cancer and large mortality due to cancer and CVDs. According to the National Institute of Cancer Prevention and Research, India recorded 2.25 million cancer cases in 2018 which makes it the major cause of mortality in the country. 

Poor economic conditions are supporting the number of mortalities caused by cancer. The absence of proper diagnostic centers for the enormous population is also the key contributing factor to the prevalence of cancer in the country. Hence, the development of peptide therapeutics across the country will significantly aid the country in battling cancer thus, driving the market growth. Moreover, improving healthcare infrastructure also enhances the peptide therapeutics market growth. As per Export.gov, the $150 billion healthcare market of India in 2018 is further expected to reach $280 billion by 2022 owing to the increased demand for specialized and quality healthcare facilities. This, in turn, is likely to create significant scope for the growth of the peptide therapeutics market.

Visit for Global Peptide Therapeutics Market Report at: https://www.omrglobal.com/industry-reports/peptide-therapeutics-market

Indian peptide therapeutics market is segmented on the basis of route of administration and application. Based on the route of administration, the market is bifurcated into parenteral administration and oral administration. On the basis of application, the market is segmented into cancer, metabolic disorder (diabetes & obesity), gastrointestinal disorders, central nervous system disorders, respiratory disorders, and others including chronic kidney diseases, osteoporosis, and autoimmune disorder. Among these applications, metabolic disorder dominates the market in India. 

Furthermore, some of the global and local players in the market include Eli Lilly & Co., Amgen Inc., AstraZeneca Plc, Teva Pharmaceuticals Co. Ltd., Novartis International AG, Flagship Biotech International Pvt. Ltd., and Hemmo Pharmaceuticals Pvt. Ltd. These companies are using several strategies to expand market share and gain a competitive advantage over their competitors. The strategies include new product launches, mergers and acquisitions, partnerships, and collaborations. 

Research Methodology

The market study of the India peptide therapeutics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.
• Authentic public databases 
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for drug manufacturing companies, pharmaceutical companies, insulin manufacturers, diabetes management companies, government organizations, regulatory bodies, hospitals & pharmacies, research institutes, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models. 

Market Segmentation:

1. India Peptide Therapeutics Market Research and Analysis by Route of Administration
2. India Peptide Therapeutics Market Research and Analysis by Application

The Report covers:

• Comprehensive research methodology of the Indian peptide therapeutics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Indian peptide therapeutics market.
• Insights about market determinants which are stimulating the Indian peptide therapeutics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.